MarketTwits
265K subscribers
78.3K photos
2.93K videos
1.1K files
82.8K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

в подборках не участвуем, партнерки не практикуем, свой канал не рекламируем, менеджеры по рекламе не нужны
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#TNXP +38% Tonix Pharmaceuticals Holding Corp - after announcing a new European patent for composition and formulation of TNX-102 SL. The patent will provide the company with market exclusivity until 2034.

#LMPX +20% LMP Automotive Holdings, - after climbing 10% on Wednesday.

#AMRX +8% Amneal Pharmaceuticals Inc -disclosed that it has received Abbreviated New Drug Application approval for EluRyng.

#GNFT +6% Genfit SA

#SFET +6% Safe-T Group Ltd - after the dropping 9% on Wednesday.

#VERU +6% Veru Inc - following Q4 results

#TTM +6% Tata Motors Limited

#CTK +4% CooTek (Cayman) Inc. - raised Q4 guidance.

#COE +4% China Online Education Group - after falling 13% on Wednesday.

#SHAK +3% Shake Shack Inc.

#SRNE +3% Sorrento Therapeutics, Inc. - after climbing 10% on Wednesday.

#TSM +3% Taiwan Semiconductor Manufacturing Company Limited

ВНИЗ

#RIBT -16% RiceBran Technologies - announced a proposed public offering of common stock.

#AKTS -9% Akoustis Technologies Inc - reported an offering of common shares. No size was disclosed.

#ASMB -6% Assembly Biosciences, Inc. -priced its 5.15 million common shares at $16.50 per share.

#LULU -4% Lululemon Athletica Inc. - reported better-than-expected earnings for its third quarter, but issued soft earnings guidance for the fourth quarter.

#PTON -3% Peloton Interactive, Inc.

#GKOS -2% Glaukos Corporation
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#AXSM +27% Axsome Therapeutics, Inc. - disclosed that AXS-05 achieved primary endpoint in GEMINI Phase 3 trial in major depressive disorder.

#RLMD +14% Relmada Therapeutics, Inc. -Guggenheim initiated coverage on Relmada Therapeutics with a Buy rating and a $64 price target.

#AMRN +12% Amarin Corporation plc - reported the FDA approval of VASCEPA to reduce cardiovascular risk. The company said it expects 2019 VASCEPA net revenue of $410 million to $425 million and 2020 VASCEPA net revenue of $650 million to $700 million.

#BNTX +11% BioNTech SE - after gaining 8% on Friday.

#ACST +10% Acasti Pharma Inc. - after surging 16% on Friday.

#DD +5% DuPont de Nemours, Inc. -IFF announced plans to merge with DuPont's nutrition & biosciences business.

#SPLK +5% Splunk Inc.

#LYV +4% Live Nation Entertainment, Inc. - after declining 7% on Friday.

#BTI +4% British American Tobacco p.l.c. - Bank of America upgraded the stock from Underperform to Buy.

#UUUU +4% Energy Fuels Inc. - after dropping 5% on Friday.

#BLDP +3% Ballard Power Systems Inc.

#ZNH +3% China Southern Airlines Company Limited

#BBL +3% BHP Group

#BCS +3% Barclays PLC -after climbing 7% on Friday.

#SYK +3% Stryker Corporation

ВНИЗ

#FENG -37% Phoenix New Media Ltd ADR

#PCG -23% PG&E Corporation -after dropping 4% on Friday.

#GOSS -11% Gossamer Bio, Inc.

#IFF -6% International Flavors & Fragrances Inc. - reported plans to merge with DuPont's nutrition & biosciences business.

#JNCE -6% Jounce Therapeutics, Inc.

#BZUN -6% Baozun Inc. - reported damage estimates of RMB53 million relating to a fire at a third-party warehouse.

#LMPX -5% LMP Automotive Holdings, Inc. -after climbing 28% on Friday.

#IPWR -4% Ideal Power Inc.

#BA -3% The Boeing Company - Boeing is weighing cutting or halting 737 MAX production, the Wall Street Journal reported.